Market News & Analysis
FTSE weaker as Evraz, ITV plunge
Fiona Cincotta March 5, 2020 9:08 PM
In a move that is fairly unusual, European markets are trading in a different direction from Wall Street - the FTSE and European markets are declining this morning, mostly from after-effects of the corona virus.
Russian steel maker Evraz is leading the FTSE fallers with an 11% decline. ITV also dropped nearly 9% after it said that it will lose at least 10% of its advertising income next month because travel firms are cancelling their ads.
Mining firms are also falling out of investors’ favour this morning on reports that China can’t sell all of the commodities it is currently producing and is instead building a large stockpile.
In a counterintuitive move, life and general insurer Aviva is moving higher, having posted a record profit for 2019. However, with coronavirus still spreading across Europe it may be too early to be bullish on a firm that will have to pay out significant amounts to cover travel insurance claims triggered by the coronavirus.
NMC Health, Kingfisher and TUI relegated to FTSE 250
The troubled health operator NMC Health is about to lose its place in the FTSE 100 as are holiday operator TUI and home-improvement chain Kingfisher. NMC’s shares are currently suspended from trading but once they restart trade they will be part of the FTSE 250. The three companies will be replaced by gold miner Fresnillo, Intermediate Capital Group and waste firm Pennon.
Pound notches higher on BOE comment
A Bank of England rate cut later this month may not be as done a deal as the market expected. The incoming governor Andrew Bailey told a Treasury Select Committee that he is waiting for more evidence on the impact of the coronavirus before casting his vote on the cut. Sterling perked up on the comment, notching higher overnight to $1.2915.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.